Cellares co-founders Omar Kurdi (left) and Fabian Gerlinghaus

Bris­tol My­ers, Cel­lares sign glob­al CAR-T deal as bio­phar­ma com­pa­nies look to di­ver­si­fy man­u­fac­tur­ing part­ners 

Cel­lares has inked its first in­ter­na­tion­al deal with Bris­tol My­ers Squibb, with the cell ther­a­py man­u­fac­tur­er not­ing it is go­ing through “tremen­dous tail­winds” from the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.